Leslie Maasdorp, vice president and chief financial officer of the New Development Bank (NDB) said, since its establishment eight years ago, the Shanghai-based bank has gone through "an incredible ... ( read original story ...)
Asian Shares Subdued Before Key Central Bank Meetings
Asian stocks ended on a muted note Friday as fresh U.S. labor market data spurred concerns that the Federal Reserve will keep ... ( read original story ...)
Governments in China are Propping Up Hong Kong’s Ailing IPO Market
Municipalities and state-backed investors that want to drum up more economic activity are buying shares in companies going public. ( read original story ...)
Stock market today: Asian shares mixed as Japan reports weaker than expected trade data
Asian shares are mixed after Japan reported weaker than expected trade data for June, with imports falling nearly 13% from a year earlier ... ( read original story ...)
UPDATE 1-China c.bank eases cross-border financing rule to temper yuan weakness
China's central bank and foreign exchange regulator on Thursday announced a relaxing of a cross-border financing rule, making it easier for domestic firms to raise funds from overseas markets and ... ( read original story ...)
Wall Street Banks Reportedly Enticing Sovereign Wealth Funds to Join Syngenta’s RMB65B IPO
Bloomberg, citing sources, reported that after Syngenta was approved to be listed in Shanghai to raise RMB65 billion, banks like Citigroup (C.US), HSBC HOLDINGS (00005.HK), JPMorga... CICC and BOCI ... ( read original story ...)
IPO Update: Advanced Biomed Finalizes $112 Million U.S. IPO Plan
Advanced Biomed has no revenue history, significant operating risks, is thinly capitalized and is seeking a high valuation at IPO. Learn more about ADVB prospects here. ( read original story ...)